Суицидальная активность больных эпилепсией при лечении антиэпилептическими препаратами
Автор: Носов С.Г., Юрьева Л.Н.
Журнал: Суицидология @suicidology
Статья в выпуске: 1 (22) т.7, 2016 года.
Бесплатный доступ
Статья является кратким обзором литературы по теме развития суицидов у больных эпилепсией, принимающих с лечебной целью различные антиэпилептические препараты (АЭП). Отмечено косвенное влияние АЭП на развитие суицидов при эпилепсии. Факторы, предрасполагающие к развитию этих психопатологических состояний с возможным развитием суицидов в условиях фармакотерапии АЭП, разделяются на три типа: связанные с реакцией личности больного на проявления эпилепсии, связанные непосредственно с эпилепсией, и связанные преимущественно с фармакотерапией АЭП. Наиболее активно суицидальную настроенность у больных эпилепсией вызывают фенобарбитал, вигабатрин, меньшую активность обнаруживают топирамат, габапентин, леветирацетам, а минимальной активностью в отношении провокации суицидов при эпилепсии обладают карбамазепин, вальпроаты.
Суициды, эпилепсия, антиэпилептические препараты
Короткий адрес: https://sciup.org/140141490
IDR: 140141490
Список литературы Суицидальная активность больных эпилепсией при лечении антиэпилептическими препаратами
- Blumer D. Epilepsy and suicide/In: Trimble M.R., Schmitz B. The neuropsychiatry of epilepsy. -Cambridge University Press. -Cambridge, 2004. -P. 107-116.
- Пылаева О.А., Мухин К.Ю., Шатенштейн А.А. Эпилепсия и риск суицида (обзор литературы)//Русский журнал детской неврологии. -2013. -Том VIII, вып. 2. -С. 23-40.
- Юрьева Л.Н. Клиническая суицидология: Монография. -Днепропетровск: Пороги, 2006. -342 с.
- Калинин В.В., Полянский Д.А. Факторы риска развития суицидального поведения у больных эпилепсией//Журнал неврологии и психиатрии им. С.С. Корсакова. -2003. -Том 103, № 3. -С. 18-21.
- Barraclough B. Suicide and epilepsy // In: Reynolds E.H., Trimble M.R. // Epilepsy and psychiatry. -Churchill Livingstone. - Edinburgh, 1981. - P. 7276.
- Trimble M.R. Antiepileptic drugs and suicide/In: Trimble M.R., Schmitz B. The neuropsychiatry of epilepsy. -Cambridge University Press. -Cambridge, 2011. -P. 143-154.
- Barry J.J., Lembke A., Gisbert P.A., Gilliam F. Affective disorders in epilepsy.In: Ettinger A.B., Kanner A.M. Psychiatric issues in epilepsy. -Wolters Kluwer, 2007. -P. 219-220.
- Пылаева О.А., Воронкова К.В., Холин А.А. Риск суицидального поведения при эпилепсии. Роль антиэпилептической терапии (обзор литературы)//Вестник эпилептологии. -2008. -№ 1. -С. 18
- Mula M., Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy//Drug Safety. -2007. -Vol. 30. -P. 555-567.
- Hesdorffer D.C., Kanner A.M. The FDA alert on suicidality and antiepileptic drugs: fire and false alarm//Epilepsia. -2009. -Vol. 50. -P. 978986.
- Potorno E., Bohn R.L., Wahl P.M. Anticonvulsant medication and risk of suicide, attempted or violent death//JAMA. -2010. -Vol. 303. -P. 1401-1409.
- Olesen J.D., Hansen P.R., Erdal J. et al. Antiepileptic drugs and risk of suicide: a nationwide study//Pharmacoepidemiology and drug safety. -2010. -Vol. 19, № 5. -P. 518-524.
- Barry J.J. The recognition and management of mood disorders as a comorbidity of epilepsy//Epilepsia. -2003. -Vol. 44, suppl 4. -P. 30-40.
- Petty F. GABA and mood disorders: a brief review and hypothesis//Journal of affective disorders. -1995. -Vol. 34. -P. 275-281.
- Bowery N.G. Pharmacology of mammalian GABAb receptors. In: Enna S.J., Bowery N.G.//The GABA receptors. -Humanna Press, New Jersey. -1997.
- Trimble M.R. Anticonvulsant-induced psychiatric disorders//Drug Safety. -1996. -Vol. 15. -P. 159-166.
- Schmitz B. Effects of antiepileptiuc drugs on mood and behaviour//Epilepsia. -2006. -Vol. 47, Suppl 2. -P. 28-33.
- Kanner A.M., Kozak A.M., Frey M. The use of sertraline in patients with epilepst: is it safe?//Epilepsy Behav. -2000. -Vol. 1. -P. 100-105.
- Jansen J.F.A., Aldenkamp A.P., Marian Majoie H.J. Functional MRI reveals declined prefrontal cortex acivation in patiens with epilepsy on topiramate therapy//Epilepsy and behavior. -2006. -Vol. 9. -P. 181-185.
- Bell G.S., Mula M., Sander J.W. Suicidality in people taking antiepileptic drugs//CNS Drugs. -2009. -Vol. 23. -P. 281-292.
- Mula M., Trimble M.R., Lhatoo S.D., Sander J.W.A.S. Topiramate and psychiatric adverse events in patients with epilepsy//Epilepsia. -2003. -Vol. 44. -P. 465-463.
- Brent D.A., Crumrine P.K., Varma R.R. Phenobar-bital treatment and major depressive disorder in children with epilepsy//Pediatrics. -1987. -Vol. 80, № 6. -P. 909-917.
- Barry J.J., Lembke A., Gisbert P.A., Gilliam F. Affective disorders in epilepsy.In: Ettinger A.B., Kanner A.M. Psychiatric issues in epilepsy. -Wolters Kluwer, 2007. -P. 219-220.
- Pylaeva O.A., Voronkova K.V., Holin A.A. Risk suicidal'nogo povedenija pri jepilepsii. Rol' anti-jepilepticheskoj terapii (obzor literatury)//Vestnik jepileptologii. -2008. -№ 1. -S. 18-27. (In Russ)
- Mula M., Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy//Drug Safety. -2007. -Vol. 30. -P. 555-567.
- Hesdorffer D.C., Kanner A.M. The FDA alert on suicidality and antiepileptic drugs: fire and false alarm//Epilepsia. -2009. -Vol. 50. -P. 978986.
- Potorno E., Bohn R.L., Wahl P.M. Anticonvulsant medication and risk of suicide, attempted or violent death//JAMA. -2010. -Vol. 303. -P. 1401-1409.
- Olesen J.D., Hansen P.R., Erdal J. et al. Antiepileptic drugs and risk of suicide: a nationwide study//Pharmacoepidemiology and drug safety. -2010. -Vol. 19, № 5. -P. 518-524.
- Barry J.J. The recognition and management of mood disorders as a comorbidity of epilepsy//Epilepsia. -2003. -Vol. 44, suppl 4. -P. 30-40.
- Petty F. GABA and mood disorders: a brief review and hypothesis//Journal of affective disorders. -1995. -Vol. 34. -P. 275-281.
- Bowery N.G. Pharmacology of mammalian GABAb receptors. In: Enna S.J., Bowery N.G.//The GABA receptors. -Humanna Press, New Jersey. -1997.
- Trimble M.R. Anticonvulsant-induced psychiatric disorders//Drug Safety. -1996. -Vol. 15. -P. 159-166.
- Schmitz B. Effects of antiepileptiuc drugs on mood and behaviour//Epilepsia. -2006. -Vol. 47, Suppl 2. -P. 28-33.
- Kanner A.M., Kozak A.M., Frey M. The use of sertraline in patients with epilepst: is it safe?//Epilepsy Behav. -2000. -Vol. 1. -P. 100-105.
- Jansen J.F.A., Aldenkamp A.P., Marian Majoie H.J. Functional MRI reveals declined prefrontal cortex acivation in patiens with epilepsy on topiramate therapy//Epilepsy and behavior. -2006. -Vol. 9. -P. 181-185.
- Bell G.S., Mula M., Sander J.W. Suicidality in people taking antiepileptic drugs//CNS Drugs. -2009. -Vol. 23. -P. 281-292.
- Mula M., Trimble M.R., Lhatoo S.D., Sander J.W.A.S. Topiramate and psychiatric adverse events in patients with epilepsy//Epilepsia. -2003. -Vol. 44. -P. 465-463.
- Brent D.A., Crumrine P.K., Varma R.R. Phenobar-bital treatment and major depressive disorder in children with epilepsy//Pediatrics. -1987. -Vol. 80, № 6. -P. 909-917.
- Ring H.A., Crellin R., Kriker S., Reynolds E.H. Vigabatrin and depression//Journal of neurology, neurosurgary and psychiatry. -1993. -Vol. 56, № 8. -P. 925-928.
- Levinson D.F., Devinsky O. Psychiatric adverse events during vigabatrin therapy//Neurology. -1999. -Vol. 53, № 7. -P. 1503-1511.
- Cugley A.L., Awartz B.E. Gabapentine-associated mood changes//Epilepsia. -1995. -Vol. 36 (Suppl. 4). -P. 53-61.
- Gotz T.J., Fuerstein A., Lais A., Meyer D. Effects of gabapentin on release of GABA from slices of rat neostriatum//Arzneim Forschung. -Vol. 43. -P. 636-638.
- Mann J.J., Malone K.M. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed in-patients//Biological psychiatry. -1997. -Vol. 41. -P. 162-171.
- Arana A., Wentworth C.E., Ayuso-Mateos J.I.,Arellano F.M. Siucidal-related events in patients treated with antiepileptic drugs//The New England journal of medicine. -2010. -Vol. 363. -P. 542551.
- Mula M., Trimble M.R., Yuen A. Psychiatric adverse events during levetiracetam therapy//Neurology. -2003. -Vol. 61. -P. 704-706.
- Born C., Dittmann S., Post R.M., Grunze h. Newer prophylactic agents for bipolar disorder and their influence on suicidality//Arch suicide Res. -2005. -Vol. 9, № 3. -P. 301-306.
- Andersohn F., Schade R., Willich S.N., Gabre E. Use of antiepileptic drugs in epilepsy and the risk of self-harm of suicidal behavior//Neurology. -2010. -Vol. 75. -P. 335-340.
- Kalinin V.V., Polyanski D.A. Gender and suicidali-ty prediction in epilepsy//Epilepsy and behavior. -2005. -Vol. 7. -P. 657-663.
- Mula M., Sander J.W. Suicidal ideation in epilepsy and levetiracetam therapy//Epilepsy and behavior. -2007. -Vol. 11. -P. 130-132.
- Lopez-Gomez M., Ramirez-Bermudez J., Campillo C. Primidone is associated with interictal depression in patients with epilepsy//Epilepsy Behav. -2005. -Vol. 6, № 3. -P. 413-416.
- Ring H.A., Crellin R., Kriker S., Reynolds E.H. Vigabatrin and depression//Journal of neurology, neurosurgary and psychiatry. -1993. -Vol. 56, №8. -P. 925-928.
- Levinson D.F., Devinsky O. Psychiatric adverse events during vigabatrin therapy//Neurology. -1999. -Vol. 53, № 7. -P. 1503-1511.
- Cugley A.L., Awartz B.E. Gabapentine-associated mood changes//Epilepsia. -1995. -Vol. 36 (Suppl. 4). -P. 53-61.
- Gotz T.J., Fuerstein A., Lais A., Meyer D. Effects of gabapentin on release of GABA from slices of rat neostriatum//Arzneim Forschung. -Vol. 43. -P. 636-638.
- Mann J.J., Malone K.M. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed in-patients//Biological psychiatry. -1997. -Vol.41. -P. 162-171.
- Arana A., Wentworth C.E., Ayuso-Mateos J.I.,Arellano F.M. Siucidal-related events in patients treated with antiepileptic drugs//The New England journal of medicine. -2010. -Vol. 363. -P. 5442-5 51.
- Mula M., Trimble M.R., Yuen A. Psychiatric adverse events during levetiracetam therapy//Neurology. -2003. -Vol. 61. -P. 704-706.
- Born C., Dittmann S., Post R.M., Grunze h. Newer prophylactic agents for bipolar disorder and their influence on suicidality//Arch suicide Res. -2005. -Vol. 9, № 3. -P. 301-306.
- Andersohn F., Schade R., Willich S.N., Gabre E. Use of antiepileptic drugs in epilepsy and the risk of self-harm of suicidal behavior//Neurology. -2010. -Vol. 75. -P. 335-340.
- Kalinin V.V., Polyanski D.A. Gender and suicidali-ty prediction in epilepsy//Epilepsy and behavior. -2005. -Vol. 7. -P. 657-663.
- Mula M., Sander J.W. Suicidal ideation in epilepsy and levetiracetam therapy//Epilepsy and behavior. -2007. -Vol. 11. -P. 130-132.
- Lopez-Gomez M., Ramirez-Bermudez J., Campillo C. Primidone is associated with interictal depression in patients with epilepsy//Epilepsy Behav. -2005. -Vol. 6, № 3. -P. 413-416.
Статья научная
